2-40.008. Rescheduling of Drug Product Under Section 893.0355

Xylazine - N-(2,6-dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine, except for xylazine as an animal drug product approved by the United States Food and Drug Administration, the use of which conforms to approved veterinary applications. The manufacture, importation, distribution, prescribing or sale of xylazine for human use is not subject to this exception.